Wound Care (Pharmacies) - Zambia

  • Zambia
  • Revenue in the Wound Care market is projected to reach US$192.90k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.27%, resulting in a market volume of US$195.50k by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,042.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.01 are generated in 2024.

Key regions: China, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care (Pharmacies) market in Zambia is experiencing steady growth due to increasing customer preferences for advanced wound care products and the rising incidence of chronic wounds. Customer preferences in the Wound Care (Pharmacies) market in Zambia are shifting towards advanced wound care products that offer better healing outcomes. Customers are increasingly seeking products that promote faster wound healing, reduce the risk of infection, and provide better pain management. This trend is driven by the growing awareness among customers about the benefits of advanced wound care products and the availability of a wider range of options in the market. Additionally, customers are also looking for products that are easy to use and offer convenience in self-care wound management. In terms of market trends, the Wound Care (Pharmacies) market in Zambia is witnessing a rise in the demand for wound dressings and bandages. This can be attributed to the increasing prevalence of chronic wounds, such as diabetic ulcers and pressure ulcers, which require regular dressing changes to promote healing. Furthermore, there is a growing focus on the development of innovative wound care products that are more effective in managing complex wounds and reducing healing time. This includes the introduction of advanced wound dressings with features like antimicrobial properties, moisture management, and improved adhesion. Local special circumstances in Zambia contribute to the development of the Wound Care (Pharmacies) market. Zambia has a high burden of chronic diseases, such as diabetes and hypertension, which are risk factors for the development of chronic wounds. This creates a significant demand for wound care products in the country. Additionally, the increasing investment in healthcare infrastructure and the expansion of the pharmaceutical sector in Zambia are also driving the growth of the Wound Care (Pharmacies) market. The government's focus on improving healthcare access and quality further supports the market development by increasing the availability of wound care products in pharmacies across the country. Underlying macroeconomic factors also play a role in the growth of the Wound Care (Pharmacies) market in Zambia. The country's stable economic growth and rising disposable income levels have led to an increase in healthcare spending. This enables customers to afford advanced wound care products and seek better treatment options for their wounds. Furthermore, the growing aging population in Zambia contributes to the demand for wound care products, as older adults are more prone to chronic wounds and require specialized care. In conclusion, the Wound Care (Pharmacies) market in Zambia is developing due to increasing customer preferences for advanced wound care products, the rising incidence of chronic wounds, local special circumstances, and underlying macroeconomic factors. The market is witnessing a shift towards advanced wound care products, particularly wound dressings and bandages, driven by the need for faster healing and better infection control. The development of the market is further supported by the high burden of chronic diseases, the expansion of healthcare infrastructure, and the country's stable economic growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)